(Q35142743)

6 August 2017

title

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy (English)

1 reference

6 August 2017

1 reference

1 reference

Laurence H Beck

1

0 references

David J Salant

object named as

David J Salant

9

0 references

Daniel C. Cattran

8

object named as

Daniel C Cattran

1 reference

6 August 2017

Fernando C Fervenza

2

1 reference

6 August 2017

David M Beck

3

1 reference

6 August 2017

Ramon G B Bonegio

4

1 reference

6 August 2017

Fahim A Malik

5

1 reference

6 August 2017

Stephen B Erickson

6

1 reference

6 August 2017

Fernando G Cosio

7

1 reference

6 August 2017

publication date

22 July 2011

1 reference

Journal of the American Society of Nephrology

6 August 2017

published in

1 reference

6 August 2017

volume

22

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

1543-1550

1 reference

describes a project that uses

6 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3148709/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Anti-phospholipase A2 receptor antibody in membranous nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Rituximab therapy for membranous nephropathy: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Management of membranous nephropathy: when and what for treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Membranous nephropathy: recent travels and new roads ahead

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Rituximab treatment of idiopathic membranous nephropathy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148709

Course of transplanted Heymann nephritis kidney in normal host. Implications for mechanism of proteinuria in membranous glomerulonephropathy

27 September 2018

1 reference

12 December 2020

Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies

1 reference

12 December 2020

First identification of an antigen in autoimmune idiopathic membranous nephropathy: toward targeted therapy?

1 reference

12 December 2020

Rituximab for idiopathic membranous nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2010111125

1 reference

6 August 2017

1 reference

6 August 2017

1 reference